
SHS appoints Jacqui as senior adviser

Germany-based healthcare and technology investor SHS has announced the appointment of Heinz Jacqui as a senior adviser, effective 1 June 2020.
Jacqui will focus on the firm's investments and developments in the area of medical technology, and will also assist with new investments, according to a statement from SHS.
Jacqui has experience in a number of organisations specialising in medical technology. In his role as global business unit president at Dräger Medical, Jacqui was responsible for the company's critical care, architectural systems and neonatal care divisions. Jacqui has previously held roles at Maquet as president and CEO, and as executive vice-president at Olympus Medical.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater